Diamond Biofund Inc. (TPE:6901)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.95
-0.30 (-1.48%)
Jul 31, 2025, 2:38 PM CST
-1.48%
Market Cap17.25B
Revenue (ttm)-2.00B
Net Income (ttm)-2.28B
Shares Out851.80M
EPS (ttm)-2.68
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume681,597
Average Volume355,842
Open20.05
Previous Close20.25
Day's Range19.75 - 20.10
52-Week Range19.20 - 42.45
Beta1.43
RSI47.14
Earnings DateMay 9, 2025

About Marinus Pharmaceuticals

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan. [Read more]

Sector Financials
Founded 2013
Employees 33
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6901
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.